Pharmacological profile of a model for central serotonin receptor activation.
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001519:Behavior / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D005277:Fenfluramine / Q000494:pharmacology; D006801:Humans; D008297:Male; D008732:Methoxydimethyltryptamines / Q000494:pharmacology; D008954:Models, Biological; D011804:Quinolines / Q000494:pharmacology*; D011814:Quipazine / Q000494:pharmacology*; D051381:Rats; D011985:Receptors, Serotonin / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects; D014364:Tryptophan / Q000494:pharmacology
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D008732:Methoxydimethyltryptamines; D011804:Quinolines; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D005277:Fenfluramine; D011814:Quipazine; D014364:Tryptophan; D006916:5-Hydroxytryptophan